Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience to be Listed on Toronto Stock Exchange; Plans Share Consolidation

NEW YORK, Feb. 27 (GenomeWeb News) - Tm Bioscience has received conditional approval to list its common shares on the Toronto Stock Exchange, the company said yesterday.


The Toronto-based company expects full approval by May 26. CEO and president Greg Hines said he hopes the listing will "greatly enhance our profile among a broader group of investors."


Tm Bioscience also plans to consolidate its shares by converting each five common shares into one. It intends to obtain shareholder approval for this share consolidation at its annual meeting, scheduled for June 2.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.